These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 2909916)

  • 1. Deficiency of pyruvate dehydrogenase complex (PDHC) in Leigh's disease fibroblasts: an abnormality in lipoamide dehydrogenase affecting PDHC activation.
    Hinman LM; Sheu KF; Baker AC; Kim YT; Blass JP
    Neurology; 1989 Jan; 39(1):70-5. PubMed ID: 2909916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical study in 28 children with lactic acidosis, in relation to Leigh's encephalomyelopathy.
    Miyabayashi S; Ito T; Narisawa K; Iinuma K; Tada K
    Eur J Pediatr; 1985 Mar; 143(4):278-83. PubMed ID: 2985393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate dehydrogenase phosphate (PDHb) phosphatase activity in fibroblasts from Leigh's disease.
    Sheu KF; Blass JP
    Neurology; 1984 Sep; 34(9):1187-91. PubMed ID: 6087208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leigh's subacute necrotizing encephalomyelopathy due to decreased activity of the pyruvate dehydrogenase complex].
    Siemes H; Goebel HH; Sengers RC; Ruitenbeek W; Trijbels JM
    Monatsschr Kinderheilkd; 1987 Dec; 135(12):821-6. PubMed ID: 3125426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome c oxidase deficiency in subacute necrotizing encephalomyelopathy.
    Arts WF; Scholte HR; Loonen MC; Przyrembel H; Fernandes J; Trijbels JM; Luyt-Houwen IE
    J Neurol Sci; 1987 Jan; 77(1):103-15. PubMed ID: 3027266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic characterization of an X-linked form of Leigh's syndrome.
    Matthews PM; Marchington DR; Squier M; Land J; Brown RM; Brown GK
    Ann Neurol; 1993 Jun; 33(6):652-5. PubMed ID: 8498846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defect in the lipoyl-bearing protein X subunit of the pyruvate dehydrogenase complex in two patients with encephalomyelopathy.
    Marsac C; Stansbie D; Bonne G; Cousin J; Jehenson P; Benelli C; Leroux JP; Lindsay G
    J Pediatr; 1993 Dec; 123(6):915-20. PubMed ID: 8229524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems analysis of energy metabolism elucidates the affected respiratory chain complex in Leigh's syndrome.
    Vo TD; Paul Lee WN; Palsson BO
    Mol Genet Metab; 2007 May; 91(1):15-22. PubMed ID: 17336115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate dehydrogenase activity is not deficient in the brain of three autopsied cases with Leigh disease (subacute necrotizing encephalomyelopathy, SNE).
    Kustermann-Kuhn B; Harzer K; Schröder R; Permanetter W; Peiffer J
    Hum Genet; 1984; 68(1):51-3. PubMed ID: 6437963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leigh's disease: a cause of arterial hypertension.
    Pamphlett R; Harper C
    Med J Aust; 1985 Sep; 143(7):306-8. PubMed ID: 4046920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on pyruvate carboxylase, pyruvate decarboxylase and lipoamide dehydrogenase in subacute necrotizing encephalomyelopathy.
    Hansen TL; Christensen E; Brandt NJ
    Acta Paediatr Scand; 1982 Mar; 71(2):263-7. PubMed ID: 6897146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic deficiency of the first component of the pyruvate dehydrogenase complex.
    Kerr DS; Ho L; Berlin CM; Lanoue KF; Towfighi J; Hoppel CL; Lusk MM; Gondek CM; Patel MS
    Pediatr Res; 1987 Sep; 22(3):312-8. PubMed ID: 3116495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of DCA treatment on the pyruvate dehydrogenase complex in patients with severe PDHC deficiency.
    Fouque F; Brivet M; Boutron A; Vequaud C; Marsac C; Zabot MT; Benelli C
    Pediatr Res; 2003 May; 53(5):793-9. PubMed ID: 12621116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoamide dehydrogenase regulation in rat brain.
    Ngo TT; Barbeau A
    Can J Neurol Sci; 1978 Feb; 5(1):105-9. PubMed ID: 647484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate carboxylase activity in subacute necrotizing encephalopathy (Leigh's disease).
    Sander J; Packman S; Berg BO; Hutchison HT; Caswell N
    Neurology; 1984 Apr; 34(4):515-6. PubMed ID: 6538306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant splicing of exon 6 in the pyruvate dehydrogenase-E1 alpha mRNA linked to a silent mutation in a large family with Leigh's encephalomyelopathy.
    De Meirleir L; Lissens W; Benelli C; Ponsot G; Desguerre I; Marsac C; Rodriguez D; Saudubray JM; Poggi F; Liebaers I
    Pediatr Res; 1994 Dec; 36(6):707-12. PubMed ID: 7898978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized spectrophotometric assay for the completely activated pyruvate dehydrogenase complex in fibroblasts.
    Schwab MA; Kölker S; van den Heuvel LP; Sauer S; Wolf NI; Rating D; Hoffmann GF; Smeitink JA; Okun JG
    Clin Chem; 2005 Jan; 51(1):151-60. PubMed ID: 15550478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic criteria in classical infantile subacute necrotizing encephalomyelopathy (Leigh's disease)].
    Sperl W; Rumpl E; Rittinger F; Pillwein K; Wick H; Henn R; Plöchl E
    Klin Padiatr; 1989; 201(2):86-92. PubMed ID: 2716238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome c oxidase deficiency in Leigh's syndrome: genetic evidence for a nuclear DNA-encoded mutation.
    Miranda AF; Ishii S; DiMauro S; Shay JW
    Neurology; 1989 May; 39(5):697-702. PubMed ID: 2540452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between activation state of pyruvate dehydrogenase complex and rate of pyruvate oxidation in isolated cerebro-cortical mitochondria: effects of potassium ions and adenine nucleotides.
    Lai JC; Sheu KF
    J Neurochem; 1985 Dec; 45(6):1861-8. PubMed ID: 3840524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.